Louise is a highly skilled scientist with experience in the design, conduct, interpretation and reporting of preclinical safety pharmacology and investigative toxicology studies in the agrochemical and pharmaceutical sectors.
After completing an honours degree in Pharmacology and a PhD in Neuroscience Louise started her career in industry in 2002 at the Syngenta Central Toxicology Laboratory (CTL) Alderley Park playing a key role in the Investigative Toxicology group and becoming Neurobiology Team Leader with responsibility for delivering neuro-toxicology studies to support agrochemicals in development and later in the life cycle. After a spell in Medical Communications following the closure of CTL, Louise joined AstraZeneca Pharmaceuticals in 2009 (Safety Pharmacology) and has extensive experience in the safety assessment of pharmaceuticals, including the design, conduct and reporting of preclinical regulatory safety pharmacology packages and overseeing the inclusion of safety pharmacology endpoints to repeat dose toxicology studies. This has included contributing to the preparation of high-level summaries and submission documents, presenting at external meetings and authoring method development papers and reviews. Latterly she specialised in the outsourcing and study monitoring of preclinical safety pharmacology studies.